Novaestiq’s Partner Croma-Pharma Announces Submission to the U.S. Food and Drug Administration for saypha® MagIQ

Novaestiq Company Logo 1st submission in the United States for saypha® line of dermal fillers represents a key Novaestiq milestone The submission is a foundational milestone for Novaestiq and supports our effort to create the next great aesthetic company” — Miles Harrison, CEO SOUTHLAKE, TX, UNITED STATES, August 21, 2024 /EINPresswire.com/ — Novaestiq Corp., a […]
The post Novaestiq’s Partner Croma-Pharma Announces Submission to the U.S. Food and Drug Administration for saypha® MagIQ first appeared on Beauty Ring Magazine.










